Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy
Comparison of Novel Articaine Lozenge Versus Placebo for Upper Gastrointestinal Endoscopy in Adults. A Randomized Double-blinded Controlled Study
Sponsor: Helsinki University Central Hospital
Listed as NCT02105090, this PHASE4 trial focuses on Abdominal Pain and Dyspepsia and remains ongoing. Sponsored by Helsinki University Central Hospital, it has been updated 9 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE4
-
Jun 2019 — Jan 2021 [monthly]
Recruiting PHASE4
▶ Show 4 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE4
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Unknown Status → Recruiting
-
Feb 2017 — Nov 2017 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status PHASE4
First recorded
Oct 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Helsinki University Central Hospital
For direct contact, visit the study record on ClinicalTrials.gov .